Advancements in technology have played a significant role in boosting the Asia Pacific Newborn Screening Market. With the introduction of new screening technologies, the accuracy and speed of screening tests have improved significantly. These advancements have made it easier and more efficient to detect potential health problems in newborns at an early stage.
One example of technological advancements in newborn screening is the use of tandem mass spectrometry (MS/MS) to screen for metabolic disorders. MS/MS is a highly sensitive and specific method that can detect a wide range of disorders. This has greatly expanded the range of disorders that can be detected through newborn screening.
In addition to MS/MS, other technological advancements such as DNA sequencing and microarray analysis have also been incorporated into newborn screening. These advancements have improved the accuracy and efficiency of screening tests, and have allowed for the detection of a wider range of conditions.
Overall, advancements in technology have played a crucial role in boosting the Asia Pacific Newborn Screening Market. As technology continues to evolve, it is likely that the market will continue to grow, and that even more conditions can be detected at an earlier stage, improving the health outcomes for newborns across the region.
The Asia Pacific newborn screening market is expected to witness significant growth in China and India due to the high birth rates in these countries and the growing focus on healthcare infrastructure development. For instance, according to Macrotrends, the present birth rate in India in 2023 is around 16.949 births per 1000 people.
Japan and South Korea are also estimated to witness high growth in the Asia Pacific newborn screening market due to the high prevalence of genetic and metabolic disorders along with the high prevalence of biotechnology companies in these countries. For instance, according to the Japan Bioindustry Association, there are around 1200 biotech startups in Japan currently.
Read More:
https://cmitoc.blogspot.com/2023/04/the-asia-pacific-newborn-screening.html
Newborn Screening Market report published by Value Market Research, which studies the future outlook of the market.
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the newborn screening market include Agilent Technologies Inc., Natus Medical Inc., Covidien Plc, Trivitron Healthcare, GE Healthcare, Masimo Corp., AB Sciex LLC, Waters Corp., PerkinElmer Inc., and Bio-Rad Laboratories Inc.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Newborn Screening Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/newborn-screening-market/download-sampleMarket DynamicsThe global newborn screening market is forecasted to grow with increasing new births, increasing prevalence of newborn disorders, rising deaths of newborn babies, expanding newborn babies services, and favorable policies.
Babies die in their first 28 days of life or the neonatal period.
The growing numbers of deaths of newborn babies and the rising prevalence of newborn diseases have caused a rise in awareness and availability of advanced screening instruments.
